Anahita Eutrope

Partech Partners SAS (Partech Partners) is a venture capital firm founded in 1982. The firm is headquartered in France.

Tiempo SAS provides chip solutions and platforms for use in semiconductors. It offers TESIC, microcontrollers, cryptoprocessors, ACC, and design services. The company was founded by Serge Maginot and Marc Renaudin in July 2007 and is headquartered in Montbonnot Sain Martin, France.

Blackfin Capital Partners SAS (Blackfin Capital Partners) is an independent Private Equity firm founded in 2008 by Eric May, Paul Mizrahi, Bruno Rostain, Laurent Bouyoux. The firm is headquartered in France, Paris with additional offices in Brussels, Belgium, and Frankfurt, Germany.

Calibrium Private Investments GmbH (formerly Aeris Capital AG) is a venture capital firm with headquarters in Zurich, Switzerland. The firm was founded in 2006.

Destygo SAS develops artificial intelligence platform specialized for the travel industry. Its solutions cover customer service, shopping, hotel booking, and reservation. The company was founded by Guillaume Henri Angel Laporte, Ilias Hicham, and Jerôme François Pierre Pakey and is headquartered in Paris, France.

LBBW Venture Capital GmbH (LBBW-VC) is part of the private equity arm and a wholly-owned subsidiary of LBBW-Landesbank Baden-Württemberg, a government-controlled regional bank based in southwestern Germany. Significant minority shareholders in LBBW include regional financial institutions and local government entities. LBBW-VC was established in 2000 and is headquartered in Stuttgart. The firm specializes in venture capital investing.

Resilience SAS is a French technology-focused biomanufacturing company founded in 2020. The company is based in France, specifically in Garches, and has subsidiaries in the country. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to advance the science of biopharmaceutical manufacturing and development to free its partners to focus on the discoveries that improve patients' lives and protect biopharmaceutical supply chains against future disruptions. Resilience is dedicated to broadening access to complex medicines such as biologics, vaccines, nucleic acid, cell/gene therapy modalities, and drug products. Additionally, the company has developed a mobile application aimed at improving the quality of life for patients by measuring, understanding, and alleviating symptoms related to treatments. The company was founded in 2020 by Céline Lazorthes, Drew Oetting, and Jonathan Benhamou, with Jonathan Benhamou serving as the CEO since then.